Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-17 4:39 pm Unchanged | 2025-11-13 | 13D | CIDARA THERAPEUTICS INC NE CDTX | RA Capital Management, L.P. | 3,372,923 10.700% | 0 (Unchanged) | Filing History |
| 2025-11-14 6:13 pm Purchase | 2025-11-12 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 2,345,277 9.900% | 1,534,606 (+189.30%) | Filing History |
| 2025-11-14 4:20 pm Purchase | 2025-09-30 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA Capital Management, L.P. | 1,960,230 9.900% | 631,652 (+47.54%) | Filing History |
| 2025-11-14 4:19 pm Sale | 2025-09-30 | 13G | Tourmaline Bio, Inc. TRML | RA Capital Management, L.P. | 0 0.000% | -2,538,925 (Position Closed) | Filing History |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | TAYSHA GENE THERAPIES INC TSHA | RA Capital Management, L.P. | 27,662,481 9.900% | 2,316,493 (+9.14%) | Filing History |
| 2025-11-14 4:17 pm Sale | 2025-09-30 | 13G | RXSIGHT INC RXST | RA Capital Management, L.P. | 0 0.000% | -3,916,825 (Position Closed) | Filing History |
| 2025-11-14 4:16 pm Purchase | 2025-09-30 | 13G | MONOPAR THERAPEUTICS INC MNPR | RA Capital Management, L.P. | 742,861 9.900% | 122,745 (+19.79%) | Filing History |
| 2025-11-14 4:15 pm Purchase | 2025-09-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA Capital Management, L.P. | 10,428,437 9.900% | 1,519,346 (+17.05%) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | DYNE THERAPEUTICS INC DYN | RA Capital Management, L.P. | 0 0.000% | -9,714,392 (Position Closed) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA Capital Management, L.P. | 3,866,733 9.500% | 1,000,000 (+34.88%) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | AVIDITY BIOSCIENCES INC RNAM | RA Capital Management, L.P. | 8,641,031 5.900% | 2,340,623 (+37.15%) | Filing History |
| 2025-11-14 4:12 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | RA Capital Management, L.P. | 1,386,167 9.900% | 291,760 (+26.66%) | Filing History |
| 2025-11-13 8:47 pm Purchase | 2025-11-11 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 25,453,010 14.600% | 38,845 (+0.15%) | Filing History |
| 2025-11-12 8:27 pm Purchase | 2025-11-04 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | RA Capital Management, L.P. | 15,302,186 7.300% | 15,302,186 (New Position) | Filing History |
| 2025-11-10 4:40 pm Purchase | 2025-11-06 | 13D | CIDARA THERAPEUTICS INC NE CDTX | RA Capital Management, L.P. | 3,372,923 10.700% | 7,400 (+0.22%) | Filing History |
| 2025-11-07 4:59 pm Sale | 2025-11-05 | 13D | SIONNA THERAPEUTICS INC SION | RA Capital Management, L.P. | 10,071,712 22.600% | -373,610 (-3.58%) | Filing History |
| 2025-11-07 4:47 pm Purchase | 2025-11-05 | 13D | LENZ THERAPEUTICS INC LENZ | RA Capital Management, L.P. | 4,265,106 13.600% | 4,500 (+0.11%) | Filing History |
| 2025-11-06 4:29 pm Sale | 2025-11-04 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 6,681,307 13.800% | -65,500 (-0.97%) | Filing History |
| 2025-11-03 4:42 pm Sale | 2025-10-30 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 0 0.000% | -20,013,733 (Position Closed) | Filing History |
| 2025-10-30 6:42 pm Sale | 2025-10-28 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 810,671 11.500% | -375,829 (-31.68%) | Filing History |